89 related articles for article (PubMed ID: 21773970)
1. Impact of radiotherapy on laryngeal cancer survival: a population-based study of 13,808 US patients.
Zhang H; Travis LB; Chen R; Hyrien O; Milano MT; Newlands SD; Chen Y
Cancer; 2012 Mar; 118(5):1276-87. PubMed ID: 21773970
[TBL] [Abstract][Full Text] [Related]
2. Five-year survival rates and time trends of laryngeal cancer in the US population.
Cosetti M; Yu GP; Schantz SP
Arch Otolaryngol Head Neck Surg; 2008 Apr; 134(4):370-9. PubMed ID: 18427002
[TBL] [Abstract][Full Text] [Related]
3. Comparative estimation of cure rates for supraglottic and glottic cancer in radiotherapy.
Goleń M; Składowski K; Maciejewski B
Neoplasma; 1999; 46(1):66-71. PubMed ID: 10355537
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes in advanced laryngeal cancer.
Megwalu UC; Sikora AG
JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):855-60. PubMed ID: 25144163
[TBL] [Abstract][Full Text] [Related]
5. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy.
Chera BS; Amdur RJ; Morris CG; Kirwan JM; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):461-6. PubMed ID: 20153124
[TBL] [Abstract][Full Text] [Related]
6. Higher laryngeal preservation rate after CO2 laser surgery compared with radiotherapy in T1a glottic laryngeal carcinoma.
Schrijvers ML; van Riel EL; Langendijk JA; Dikkers FG; Schuuring E; van der Wal JE; van der Laan BF
Head Neck; 2009 Jun; 31(6):759-64. PubMed ID: 19260127
[TBL] [Abstract][Full Text] [Related]
7. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.
Hoffman HT; Porter K; Karnell LH; Cooper JS; Weber RS; Langer CJ; Ang KK; Gay G; Stewart A; Robinson RA
Laryngoscope; 2006 Sep; 116(9 Pt 2 Suppl 111):1-13. PubMed ID: 16946667
[TBL] [Abstract][Full Text] [Related]
8. Supraglottic laryngeal cancer: analysis of treatment results.
Sessions DG; Lenox J; Spector GJ
Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
[TBL] [Abstract][Full Text] [Related]
9. The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation?
Jones AS; Fish B; Fenton JE; Husband DJ
Head Neck; 2004 Feb; 26(2):127-35. PubMed ID: 14762881
[TBL] [Abstract][Full Text] [Related]
10. Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.
Canaday DJ; Regine WF; Mohiuddin M; Zollinger W; Machtay M; Lee J; Schultz D; Rudoltz MS
Radiat Oncol Investig; 1999; 7(1):42-8. PubMed ID: 10030623
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
[TBL] [Abstract][Full Text] [Related]
13. Duration of symptoms: impact on outcome of radiotherapy in glottic cancer patients.
Hansen O; Larsen S; Bastholt L; Godballe C; Jørgensen KE
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):789-94. PubMed ID: 15708258
[TBL] [Abstract][Full Text] [Related]
14. Second course of radiation for new primary head-and-neck cancer: population-based study of survival.
Milano MT; Zhang H
Am J Clin Oncol; 2011 Aug; 34(4):367-71. PubMed ID: 20859195
[TBL] [Abstract][Full Text] [Related]
15. Management of T3N1 glottic carcinoma: therapeutic outcomes.
Spector JG; Sessions DG; Lenox J; Simpson J
Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
[TBL] [Abstract][Full Text] [Related]
16. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease.
Cellai E; Frata P; Magrini SM; Paiar F; Barca R; Fondelli S; Polli C; Livi L; Bonetti B; Vitali E; De Stefani A; Buglione M; Biti G
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1378-86. PubMed ID: 16095847
[TBL] [Abstract][Full Text] [Related]
17. Transoral laser microsurgery for advanced laryngeal cancer.
Hinni ML; Salassa JR; Grant DG; Pearson BW; Hayden RE; Martin A; Christiansen H; Haughey BH; Nussenbaum B; Steiner W
Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1198-204. PubMed ID: 18086960
[TBL] [Abstract][Full Text] [Related]
18. Impact of surveillance on survival after laryngeal cancer in the medicare population.
Francis DO; Yueh B; Weymuller EA; Merati AL
Laryngoscope; 2009 Dec; 119(12):2337-44. PubMed ID: 19718759
[TBL] [Abstract][Full Text] [Related]
19. The management of glottic and supraglottic cancers of the larynx in relation to neck metastasis.
Yücetürk AV; Celik O; Eskiizmir G
Kulak Burun Bogaz Ihtis Derg; 2003 Nov; 11(5):129-33. PubMed ID: 15542939
[TBL] [Abstract][Full Text] [Related]
20. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]